← All organizations
Highest phase reached
Phase 4
Acquired by Hafslund on Jan 1, 1986
Timeline
1920s
- Jan 1, 1922
Koren & Gedde— Acquired
1980s
- Jan 1, 1986
Hafslund— Acquired By
1990s
- Jan 1, 1996
Nycomed— Founded
2000s
- Oct 1, 2004
terconazole— NDA Secondary Org
Drugs by trial phase (23 distinct, 29 trials)
Phase 4 (10 own, 0 via acquisition)
Phase 3 (10 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Phase 1 (2 own, 0 via acquisition)
Indications
Studied for
- Asthma
- Back Pain
- Bone Diseases
- Breakthrough Pain
- Cancer Pain
- Chronic Pain
- Diabetes Mellitus, Type 2
- Esophagitis, Peptic
- Fractures, Bone
- Gastroesophageal Reflux
- Hemorrhage
- Hernia
- Intraoperative Complications
- Liver Diseases
- Osteoporosis
- Polyneuropathies
- Postoperative Pain
- Renal Insufficiency
- Short Bowel Syndrome
- Spinal Fractures
- Stroke
- Syndrome
Marketed drugs (2)
Subsidiaries (1 direct, 1 total across the full acquisition tree)
Recent trials (29)
- NCT01386541Lead sponsorPhase 1Jun 1, 2011
- NCT01388738CollaboratorPhase 3Jan 1, 2011
- NCT01047488CollaboratorPhase 4Feb 1, 2010
- NCT01052012CollaboratorPhase 3Dec 1, 2009
- NCT01028924Lead sponsorPhase 1Nov 1, 2009
- NCT01028768Lead sponsorPhase 1Oct 1, 2009
- NCT00930644CollaboratorPhase 3Sep 1, 2009
- NCT00818363CollaboratorPhase 2Dec 1, 2008
- NCT00798967CollaboratorPhase 3Nov 1, 2008
- NCT00713661Lead sponsorPhase 2Jun 1, 2008
- NCT00713258Lead sponsorPhase 4Apr 1, 2008
- NCT00583518Lead sponsorPhase 4Nov 1, 2007
- NCT00479037Lead sponsorPhase 4Apr 1, 2007
- NCT00440401Lead sponsorPhase 4Feb 1, 2007
- NCT00496392Lead sponsorPhase 3Jan 1, 2007
Details
- Founded
- Zurich, CH Jan 1, 1996
- Last known activity
- Jun 1, 2011
Notes
Acquired by Takeda